- $53.39m
- $7.36m
- $37.25m
- 60
- 42
- 59
- 54
Annual income statement for Eargo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 23.2 | 32.8 | 69.2 | 66.5 | 37.2 |
| Cost of Revenue | |||||
| Gross Profit | 11.7 | 17 | 47.3 | 38.6 | 14.3 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 55.3 | 76.8 | 106 | 223 | 150 |
| Operating Profit | -32.1 | -44 | -36.5 | -157 | -113 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -33.8 | -44.5 | -39.9 | -158 | -157 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -33.8 | -44.5 | -39.9 | -158 | -157 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -33.8 | -44.5 | -39.9 | -158 | -157 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -33.8 | -44.5 | -30 | -158 | -157 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -7.77 | -10.4 | -14.8 | -63.4 | -39.6 |
| Dividends per Share |